Tag: Immatics

Immatics specializes in T-cell receptors (TCRs) and has made significant strides in immunotherapy. With bispecific antibodies in phase three and promising TCR therapies, the company is positioning itself as a leader in the immuno-oncology space. The founder, Harpreet Singh, was on the show recently for episode 20, so please feel free to check it out.